Skip to content

NAGE NAGE Return on equity

Return on equity at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
11.9%+5.5pp
eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
-185.8%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
17.1%-13.0pp
NuSkin Enterprises logo
NuSkin EnterprisesNUS
7%+5.0pp
USANA Health Sciences logo
USANA Health SciencesUSNA
3.2%-7.6pp
Abbott logo
AbbottABT
12.4%-18.4pp

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Calculated from NAGE’s reported figures.

Based on trailing twelve months.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's return on equity?
NAGE (NAGE) reported return on equity of 27.1% in Q1 2026.
How has NAGE's return on equity changed year-over-year?
NAGE's return on equity decreased by 19.1% year-over-year, from 33.5% to 27.1%.
What is the long-term trend for NAGE's return on equity?
Over 3 years (2021 to 2025), NAGE's return on equity has grown at a -36.9% compound annual growth rate (CAGR), from -112.7% to 28.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.